Global Carmustine Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Carmustine Product Introduction
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Carmustine Market Size Growth Rate by Type
  • 1.4.2 100mg Injection
  • 1.4.3 125mg Injection
• 1.5 Market by Application
  • 1.5.1 Global Carmustine Market Size Growth Rate by Application
  • 1.5.2 Glioma
  • 1.5.3 Glioblastoma Multiforme
  • 1.5.4 Medulloblastoma and Astrocytoma
  • 1.5.5 Multiple Myeloma
  • 1.5.6 Lymphoma
  • 1.5.7 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Carmustine Market Size
  • 2.1.1 Global Carmustine Revenue 2014-2025
  • 2.1.2 Global Carmustine Sales 2014-2025
• 2.2 Carmustine Growth Rate by Regions
  • 2.2.1 Global Carmustine Sales by Regions
  • 2.2.2 Global Carmustine Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Carmustine Sales by Manufacturers
  • 3.1.1 Carmustine Sales by Manufacturers
  • 3.1.2 Carmustine Sales Market Share by Manufacturers
• 3.2 Carmustine Revenue by Manufacturers
  • 3.2.1 Carmustine Revenue by Manufacturers (2014-2019)
  • 3.2.2 Carmustine Revenue Share by Manufacturers (2014-2019)
• 3.3 Carmustine Price by Manufacturers
• 3.4 Carmustine Manufacturing Base Distribution, Product Types
  • 3.4.1 Carmustine Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Carmustine Product Type
  • 3.4.3 Date of International Manufacturers Enter into Carmustine Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type

• 4.1 Global Carmustine Sales by Type
• 4.2 Global Carmustine Revenue by Type
• 4.3 Carmustine Price by Type

5 Breakdown Data by Application

• 5.1 Overview
• 5.2 Global Carmustine Breakdown Data by Application

6 North America

• 6.1 North America Carmustine by Country
  • 6.1.1 North America Carmustine Sales by Country
  • 6.1.2 North America Carmustine Revenue by Country
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Carmustine by Type
• 6.3 North America Carmustine by Application

7 Europe

• 7.1 Europe Carmustine by Country
  • 7.1.1 Europe Carmustine Sales by Country
  • 7.1.2 Europe Carmustine Revenue by Country
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Carmustine by Type
• 7.3 Europe Carmustine by Application

8 Asia Pacific

• 8.1 Asia Pacific Carmustine by Country
  • 8.1.1 Asia Pacific Carmustine Sales by Country
  • 8.1.2 Asia Pacific Carmustine Revenue by Country
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Carmustine by Type
• 8.3 Asia Pacific Carmustine by Application

9 Central & South America

• 9.1 Central & South America Carmustine by Country
  • 9.1.1 Central & South America Carmustine Sales by Country
  • 9.1.2 Central & South America Carmustine Revenue by Country
  • 9.1.3 Brazil
  • 9.1.4 Argentina
• 9.2 Central & South America Carmustine by Type
• 9.3 Central & South America Carmustine by Application

10 Middle East and Africa

• 10.1 Middle East and Africa Carmustine by Country
  • 10.1.1 Middle East and Africa Carmustine Sales by Country
  • 10.1.2 Middle East and Africa Carmustine Revenue by Country
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Carmustine by Type
• 10.3 Middle East and Africa Carmustine by Application

11 Company Profiles

• 11.1 Amneal Pharms
  • 11.1.1 Amneal Pharms Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Amneal Pharms Carmustine Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Amneal Pharms Carmustine Products Offered
  • 11.1.5 Amneal Pharms Recent Development
• 11.2 Arbor Pharms
  • 11.2.1 Arbor Pharms Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Arbor Pharms Carmustine Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Arbor Pharms Carmustine Products Offered
  • 11.2.5 Arbor Pharms Recent Development
• 11.3 Emcure Pharms
  • 11.3.1 Emcure Pharms Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Emcure Pharms Carmustine Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Emcure Pharms Carmustine Products Offered
  • 11.3.5 Emcure Pharms Recent Development
• 11.4 Navinta
  • 11.4.1 Navinta Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Navinta Carmustine Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Navinta Carmustine Products Offered
  • 11.4.5 Navinta Recent Development
• 11.5 STI Pharma
  • 11.5.1 STI Pharma Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 STI Pharma Carmustine Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 STI Pharma Carmustine Products Offered
  • 11.5.5 STI Pharma Recent Development
• 11.6 Obvius Pharmaceuticals
  • 11.6.1 Obvius Pharmaceuticals Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Obvius Pharmaceuticals Carmustine Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Obvius Pharmaceuticals Carmustine Products Offered
  • 11.6.5 Obvius Pharmaceuticals Recent Development
• 11.7 MGI Pharma
  • 11.7.1 MGI Pharma Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 MGI Pharma Carmustine Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 MGI Pharma Carmustine Products Offered
  • 11.7.5 MGI Pharma Recent Development
• 11.8 Marcan Pharmaceuticals
  • 11.8.1 Marcan Pharmaceuticals Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Marcan Pharmaceuticals Carmustine Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Marcan Pharmaceuticals Carmustine Products Offered
  • 11.8.5 Marcan Pharmaceuticals Recent Development
• 11.9 Eisai
  • 11.9.1 Eisai Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Eisai Carmustine Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Eisai Carmustine Products Offered
  • 11.9.5 Eisai Recent Development
• 11.10 Bristol-Myers Squibb
  • 11.10.1 Bristol-Myers Squibb Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Bristol-Myers Squibb Carmustine Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Bristol-Myers Squibb Carmustine Products Offered
  • 11.10.5 Bristol-Myers Squibb Recent Development
• 11.11 Pharmaplan
• 11.12 Sanli Ilac
• 11.13 Zydus Pharmaceuticals
• 11.14 Tianjin Kingyork

12 Future Forecast

• 12.1 Carmustine Market Forecast by Regions
  • 12.1.1 Global Carmustine Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Carmustine Revenue Forecast by Regions 2019-2025
• 12.2 Carmustine Market Forecast by Type
  • 12.2.1 Global Carmustine Sales Forecast by Type 2019-2025
  • 12.2.2 Global Carmustine Revenue Forecast by Type 2019-2025
• 12.3 Carmustine Market Forecast by Application
• 12.4 North America Carmustine Forecast
• 12.5 Europe Carmustine Forecast
• 12.6 Asia Pacific Carmustine Forecast
• 12.7 Central & South America Carmustine Forecast
• 12.8 Middle East and Africa Carmustine Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Carmustine Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details